Centralized and Decentralized Supplies of COVID-19 Vaccines to Developing Countries: Both COVAX and Competition Motivated by Vaccine Diplomacy Play Each Role

DOI Web Site 5 References

Bibliographic Information

Other Title
  • 開発途上国へのCOVID-19ワクチン供給のための協調と競争：COVAXとワクチン外交の相互作用

Abstract

<p>2001 WTO Doha Declaration and Advance Market Commitment (AMC), which were both designed to promote supply of medicines and vaccines for HIV/AIDS and neglected tropical diseases in the beginning of this century, were applied for furthering COVID-19 vaccine supply to developing countries in 2021. AMC was developed into COVAX, which is a COVID-19 vaccine distribution mechanism. Both COVAX and self-motivated vaccine developers individually contributed to swift inventions of a variety of COVID-19 vaccines and considerably low prices of them. The centralized policy instrument, ­i.e. COVAX, and decentralized innovation activities made by private pharmaceuticals firms, played important and reinforcing roles each other.</p>

Journal

  • KOKUSAI KEIZAI

    KOKUSAI KEIZAI 73 (0), 155-184, 2022

    The Japan Society of International Economics

References(5)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top